M&A Deal Summary

Smith & Nephew Acquires CartiHeal

On November 24, 2023, Smith & Nephew acquired medical products company CartiHeal from Bioventus for 330M USD

Acquisition Highlights
  • This is Smith & Nephew’s 23rd transaction in the Medical Products sector.
  • This is Smith & Nephew’s 5th largest (disclosed) transaction.
  • This is Smith & Nephew’s 1st transaction in Israel.

M&A Deal Summary
Date 2023-11-24
Target CartiHeal
Sector Medical Products
Buyer(s) Smith & Nephew
Sellers(s) Bioventus
Deal Type Divestiture
Deal Value 330M USD

Target

CartiHeal

Kfar-Saba, Israel
CartiHeal is a privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal founded in 2009 and is based in Kfar-Saba, Israel.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Smith & Nephew

Watford, United Kingdom
Category Company
Founded 1856
Sector Medical Products
Employees18,452
Revenue 5.5B USD (2023)
DESCRIPTION

Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, United Kingdom.

DEAL STATS #
Overall 34 of 34
Sector (Medical Products) 23 of 23
Type (Divestiture) 9 of 9
Country (Israel) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 5 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-01 Smith+Nephew - Two Wound-healing Cell Therapy Assets

Watford, United Kingdom

Smith+Nephew - Two Wound-healing Cell Therapy Assets EpiDex®, is an autologous epidermal equivalent that provides a surgery-free approach to healing chronic venous leg ulcers (VLUs). Healiva®002, is an off-the-shelf allogeneic cell therapy that has previously demonstrated clinical efficacy in healing VLUs that are resistant to standard treatments.

Sell -

Seller(S) 1

SELLER

Bioventus

Durham, North Carolina, United States
Category Company
Founded 2011
Sector Medical Products
Employees995
Revenue 512M USD (2023)
DESCRIPTION

Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Divestiture) 1 of 2
Country (Israel) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-04 CartiHeal

Kfar-Saba, Israel

CartiHeal is a privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal founded in 2009 and is based in Kfar-Saba, Israel.

Buy $315M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-01 Bioventus - Advanced Rehabilitation Business

United States

Bioventus' Advanced Rehabilitation Business is a provider of medical products critical for helping patients with stroke and other neuromuscular conditions in their rehabilitation journey.

Sell $45M
Mergr

Product

Company

Legal